Antibody binding activity specific to monocyte scavenger receptor CD36 is frequently detectable in the plasma of patients with antiphospholipid syndrome
Authors:
- 16 September 2023
- journal article
- letter
- Published by SAGE Publications in Lupus
- Vol. 32 (11) , 1353-1355
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (18K07468)
This publication has 9 references indexed in Scilit:
- aCL/β2GPI and aPS/PT show synergic thrombogenic effects in suppressing anticoagulant activity of APC and stimulating tissue factor expression and TNF-α secretion by mononuclear cellsThrombosis Research, 2019
- Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibodyRheumatology, 2013
- The involvement of CD36 in monocyte activation by antiphospholipid antibodiesLupus, 2013
- Antiphospholipid syndromeThe Lancet, 2010
- A BRIEF COMMUNICATIONExperimental Biology and Medicine, 2009
- Inflammation, atherosclerosis, and arterial thrombosis: Role of the scavenger receptor CD36Cleveland Clinic Journal of Medicine, 2009
- Involvement of p38 MAPK in the up‐regulation of tissue factor on endothelial cells by antiphospholipid antibodiesArthritis & Rheumatism, 2005
- The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti- 2Glycoprotein I antibodiesInternational Immunology, 2004
- Anti‐CD36 antibodies in patients with lupus anticoagulant and thrombotic complicationsBritish Journal of Haematology, 1994